ALCAR fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Carmat SA engages in the developing of implantable orthotropic and biocompatible artificial heart. Its artificial heart is intended for patients with advanced cardiac insufficiency that is ineligible for a transplant and have exhausted all medication alternatives. The firm also develops electrical power supply system and telediagnostics system. The company was founded by Pouletty Philippe and Alain Carpentier on June 25, 2008 and is headquartered in Vélizy Villacoublay, France.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
ALCAR does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company